Laryngoscope Investigative Otolaryngology (Jun 2019)

Does perioperative oxandrolone improve nutritional status in patients with cachexia related to head and neck carcinoma?

  • Angela M. Osmolak,
  • Cristine N. Klatt‐Cromwell,
  • Amber M. Price,
  • Jose A. Sanclement,
  • Greg A. Krempl

DOI
https://doi.org/10.1002/lio2.268
Journal volume & issue
Vol. 4, no. 3
pp. 314 – 318

Abstract

Read online

Background Cancer cachexia affects up to over 50% of advanced head and neck cancer (HNC) patients. To date, the potential utility of anabolic steroids in perioperative cachectic HNC patients has not been determined. Methods Retrospective review of pre‐ and post‐oxandrolone administration prealbumin levels in 18 perioperative HNC patients between October 2007 and October 2014 at a tertiary academic medical center. Results The median pretreatment prealbumin was 88.5 mg/L. The median post‐treatment prealbumin was 227 mg/L. The median interval improvement of the prealbumin level was 131.5 mg/L. The median differences between the pretreatment and post‐treatment prealbumin levels were found to be statistically significant (P < .001). Subjective improvement in wound healing was also observed. Conclusions Perioperative administration of oxandrolone resulted in objective improvements in prealbumin levels and subjective improvements in surgical wounds. Oxandrolone administered 10 mg twice daily (BID) for 10 days may be a useful adjunct in the perioperative care of nutritionally deficient HNC patients who are at risk for or have demonstrated impaired wound healing. Level of Evidence 3

Keywords